Clean-up expands to US; Sun recalls 1 million units of anti-allergic drug made by Ranbaxy armSun Pharmaceutical Industries has initiated a recall of a little over a million boxes of Loratadine, an......
Ranbaxy’s US office is faced with an exodus. At least five top executives including country head Venkatachalam Krishnan and heads of various key departments such as finance, legal, and sales......
Shares of Ranbaxy Laboratories rose more than 5 per cent after the company announced a US regulatory approval for a hypertension drug to be launched by one of its subsidiaries. The stock rose by......
Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......
Ranbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to defective packaging. According to the US health......